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1. Introduction
  The development of the Indian poultry industry in general, 
Namakkal layer industry in particular, is remarkably fast 
and it is growing on leaps and bounds with respect to 
poultry egg production. But it is surprisingly sad to note that 
the development in poultry vaccinology is pacing far behind 
the production achievements. The vaccines used in the 
poultry industry are as old as the childhood of the industry.
  Recombinant vaccines for several diseases of poultry have 
recently been produced in the laboratories in India and 
abroad in an effort to eliminate some of the disadvantages 
of live and killed vaccines. Genetically modified viruses 
that possess large regions of their genome and lack the 
genes for the infection associated proteins are of recent 
interest as they can be used as marker vaccines[1,2]. These 
modified viruses also serve as viral vectors for inserting 
genes of other viruses[3]. However, recombinant vaccines 
could neither totally replace the conventional vaccines now 
preferred over conventional vaccines by the commercial 
poultry industry.
  NDV is an Office International des Epizooties list A 
pathogen that causes a serious respiratory and neurological 
disease in all species of birds and is an economically 
important infectious agent, causing substantial losses 
to the poultry industry. Newcastle disease varies in the 
degree of severity, ranging from an unapparent infection 
to severe disease causing 100% mortality. In China, the 
first Newcastle disease outbreak was recorded in 1928, and 
the standard strain F48E9 was isolated in 1948 for the first 
time[4].
 Unique to paramyxoviruses, the Haemagglutinin-
neuraminidase (HN) protein of Newcastle Disease Virus 
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(NDV) has the activity of haemagglutinating the red blood 
cells (RBC) and it has been shown that NDV can bind to 
and haemagglutinate amphibian, reptilian, avian, guinea 
pig, mouse and human RBCs[5]. The haemagglutination 
seen with NDV is due to the HN protein’s ability to bind to 
RBCs and to other cells with the proper sialic (neuraminic) 
acid receptors[6]. Haemagglutination of RBCs has provided 
a powerful tool in the diagnosis of NDV. Burnet (1942) 
demonstrated that NDV anti-sera prevented the agglutination 
of RBCs by NDV. This discovery provided the basis of the 
haemagglutination-inhibition (HI) test that has been the 
standard for the diagnosis and measuring the antibody 
response to natural or vaccinal exposure of birds to NDV. 
In present days, the whole virus cultivated in embryonated 
chicken eggs is used as a source of haemagglutinin protein 
and HI assay is the only method widely followed worldwide.
  The serotypes and genotypes of Infectious Bronchitis Virus 
(IBV) was mainly determined by the Spike (S)1 glycoprotein. 
A prevalent IBV strain ZY3 was isolated and the highly 
antigenic region of its S1 gene was amplified and expressed 
in Escherichia coli (E. coli) using the pET-32a (+) vector[7].
  The present study aims at cloning the entire HN gene into 
the available prokaryotic expression vector system and use 
the expressed HN protein in the cell lysate of the bacteria as 
the source of haemagglutinin required for the routine HI tests 
in the laboratory for at least sero-monitoring of vaccination 
response. If the hypothesis is proved successful, the labour 
intensive laboratory cultivation of virus in embryonated 
chicken eggs and the recontamination of the environment 
through possible laboratory spillage of the virus can greatly 
be obviated. 
 
2. Materials and methods
  Tissue samples from ailing birds supplied by the kind 
courtesy of Avian Disease Laboratory, Namakkal, Tamil 
Nadu, India, were used for virus isolation through chicken 
embryo cultivation. Total RNA from infected eggs was 
isolated using TRIZOL reagent as per manufacturer’s 
specification which is a single step isolation method[8,9]. The 
isolated RNA was used as template for amplification of HN 
gene by RT-PCR.
  Primers encompassing full length HN gene were designed 
from the published sequence. The oligonucleotides were 
reconstituted to 1 nmol/毺L concentration in sterile Tris 
EDTA (TE) as a stock and stored at -70 ℃. The primers were 
used at working dilution of 20 pmol/毺L in filtered distilled 
water (FQW). The sequences of the primers were as follows:
Forward 5’-GCG GGA TCC ATG GAC CGC GCC GTT AGC CAA 
AT-3’ 
Reverse 5’-GCG AAG GCTT CTA GCC AGA CCT GGC TTC 
TCT-3’
The position of the primers with this gene is 6412 to 8145 
location in locus NC_002617 of NDV B1 complete genome in 
NCBI nucleotide database.
  cDNA for the HN RNA was synthesized in 0.5 mL micro 
centrifuge tube. Eight 毺L of total RNA was mixed with 2 毺L 
of HN specific reverse primer (50 pmol) and they were heated 
in boiling water for 5 minutes, then immediately chilled in 
ice for 5 minutes. To the RNA primer mixture, 4 毺L of 5伊 
RT buffer (250 mM Tris HCl, 25 mM MgCl2, 300 mM KCl), 
2 毺L of 10 mM each of dNTPs, 30 U of ribonuclease 
inhibitor, 1 毺L (15u/毺L) of avian myeloblastosis virus 
(AMV) reverse transcriptase (Promega, USA) and 3 毺L of 
nuclease free water were added and the reaction mixture was 
incubated at 42 ℃ for 90 min for cDNA synthesis. Later the 
reaction was terminated by heating the mixture at 90 ℃ for 
3 min. HN gene was amplified by subjecting 2 毺L of cDNA 
to PCR in a reaction mixture contains PCR assay buffer (25 
mM Tris HCL, 10 mM KCL, 1.5 mM MgCl2), 0.1 mM dNTP’s, 
50 pmol each of forward and reverse primers, 0.5 unit of Pfu 
polymerase (Promega, USA).
  Optimum annealing temperature was determined by 
employing gradient PCR. Reactions were carried out in 
a thermal cycler (Techne, USA) with forward and reverse 
primers using the reaction conditions; initial denaturation for 
3 min at 94 ℃, followed by 35 cycles of denaturation at 94 ℃ 
for 2 min, annealing at 55-60 ℃ (gradient) for 1 min and 
extension at 72 ℃ for 2 min. Finally, the reaction was held 
at 72 ℃ for 10 min to complete the synthesis of unfinished 
products. Specific and optimum amplification of the gene 
was seen at 58 ℃ of annealing temperature. Subsequently 
the gene was amplified at 58 ℃ and the amplified PCR 
product (1.7 kb) was purified from low melting point agarose 
gel, as per the standard protocol, for further cloning.
  The purified PCR fragment was digested with BamHI and 
HindIII (Promega, USA) as per standard protocol and ligated 
into BamH1 and HindIII digested pBSKII+ plasmid. Ligation 
reaction was carried out as per standard protocol using T4 
DNA ligase (Promega, USA). Briefly 50 ng of insert DNA was 
mixed with 25 ng of linearized vector in the presence of 1
暳ligase buffer (supplied by manufacturer). The ligated 
mixture (1 mL) was transferred into competent E. coli DH5毩 
cells and plated on LB agar containing 50 mg/mL ampicillin, 
1 mM IPTG and 0.02% X-gal. The white colonies observed 
after 16 h of incubation were screened for the presence of 
the vector with insert by colony lysis and release of the 
insert by restriction enzyme digestion. One of the positive 
colonies was designated as pBND-HN.
 The insert was released from pBND-HN and ligated into 
linearized pET 32a+ (Novagen, USA) expression vector. A 
few pETND-HN plasmid DNA was transferred into electro 
competent E. coli BL21 (DE3) PlysS cells by electroporation 
and plated in ampicilline-agar plate and incubated 16 hrs 
at 37 ℃. A few colonies were picked and grown in LB broth 
overnight in the presence of ampicillin. Cells were collected 
by centrifugation at 6 000 g at 4 ℃, suspended 5 volumes 
of fresh LB broth without ampicillin, grown to 0.6 OD at 
A600 nm and to that IPTG was added to 0.4 mM for protein 
induction. Protein induction was done at 30 ℃ for 3 hr in a 
shaking incubator.
  The cells were collected by centrifugation, suspended in TE 
containing 10 mM Phenyl methyl sulphonyl fluoride (PMSF) 
and lysed by freezing-thawing twice. The crude lysate 
proteins from the induced clone were analysed by sodium 
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE). The crude form of protein was checked for the HA 
activity with 1% washed chicken RBC. The specificity of HA 
activity was also ascertained by HI test using NDV specific 
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serum.
3. Results
   
  Upon transformation of the E. coli DH5 alpha cells with the 
ligated mixture and plating of the transformed cells on LB-
ampicillin-agar plates, several ampicillin resistant colonies 
could be seen on the plates. These may represent E. coli with 
pET 32a+plasmid and with or without inserted DNA. Colonies 
were screened by colony lysis, the plasmid DNA from the 
colony showing slower mobility was subjected for restriction 
digestion and analyzed by agarose gel electrophoresis 
using DNA molecular size markers (Figure 1). The actual RT 
and PCR product obtained both in the pBKII+ and pET32a+ 
clones, each in these forms namely clones without insert 
(HN gene), with insert, and along with released insert. Figure 
1 showed well separated DNA fragments could be seen in 
the gel, the lower fragment of 1.7 kb may correspond to the 
inserted HN gene and the upper band of above 5.0 kb may 
correspond to the linearized pET 32+ vector of 5.9. This 
recombinant plasmid has been designated as pETND-HN. 
  Well separated protein bands could be seen both in case of 
induced and un-induced cell lysates which may be of both 
host and plasmid origin. However, there was an additional 
thick Coomassiebrilliant Blue (CBB) stained protein band of 
size corresponding to 81 kDa which may be of insert origin. 
As per the derived amino acid (aa) sequence the expressed 
from the cloned insert is expected be of 63 kDa. Along with 
the fusion tag of 18 kDa from the vector the total size of the 
fusion protein would be 81 kDa, which was the observed 
size.  The crude protein gave HA at 1 in 40 dilutions (Figure 
2). The crude protein expressed by the true positive clone, 
which gave haemagglutination with chicken RBC up to 1 
in 40 dilution was also subjected to neutralization test with 
equal volume of known NDV positive serum and the results 
are shown in Figure 3. Formation of clear and complete 
haemagglutination of RBC was seen in the wells (Row 1, 
wells 1 to 4, Figure 3).  
L1             L2           L3           L4           L5           L6            L7          L8
Figure 1. The actual RT and PCR product.
Lane 1: Promega 1 kb ladder, Lane 2: RTPCR product, Lane 3: 
Digested pBSKII+ vector, Lane 4: Single Digested pBSKII+ insert, 
Lane 5: Insert release from pBSKII+, Lane 6: Digested pET32a+ 
vector, Lane 7: Single Digested pET32a+ vector + insert, Lane 8: 
Insert release from pET32a+. 
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Figure 2. CBB stained polyacrylamide gel electrophoresis of the 
crude protein expressed by the pET32a clone in  BL21(DE3) pLYS’S 
cells.
Lanes 1 and 4: Protein expressed by uninduced clones, Lanes 2 and 
3: Proteins expressed by induced clones yielding about 81 kDa of 
HN protein (63 kDa) plus 18 kDa of fusion protein, Lane 5: Protein 
expressed by the vector, Lane 6: Protein molecular weight marker.
      
1
2
Figure 3.  HA activity of the induced protein with chicken RBC.
1: HA activity of crude protein of positive clone-HA in four wells i.e. 
1 in 40 dilution;
2: HA activity of crude protein expressed by vector (control)-No HA 
activity. 
4. Discussion
  The focus of this study is to explore the possibility of 
producing the HN protein of NDV (locally isolated B1 strain) 
and study its activity in haemagglutination for the purpose 
of using it in serological assay of NDV antibodies. For 
expression of HN gene in E. coli, BL21 (DE3), pET32a+vectors 
were used which have necessary features for over expression 
of cloned genes[10,11]. The HN gene of NDV amplified by RT-
PCR[9,12] was inserted down stream of strong T7 promoter, 
ribosome binding site and initiation signal and upstream of 
strong terminator signal. Presence of thyrodoxin tag makes 
the protein soluble thereby maintaining the biological 
activity of the fusion protein. Though the quantity of HN 
protein expressed by the clone has not been measured, the 
intensity of the stained band may represent around 10% of 
the total proteins. Another important benefit of this system 
is its ability to maintain target genes transcriptionally silent 
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in the uninduced state[13]. The crude protein was confirmed 
of their specificity only by size measurement along with 
known protein molecular weight markers. The expressed crude 
protein of size 81 kDa inclusive of 63.2 kDa of haemagglutinin 
protein and 18kDa of fusion protein of the host cell is 
clearly appreciable. Haemagglutinin protein of HN gene 
of NDV possesses a specific affinity to bind on receptors 
of normal chicken RBC and this process make the RBC to 
become agglutination on mixing. This reaction is termed as 
haemagglutination and this reaction is being used to assess 
the antibody of NDV by an assay called Haemagglutination 
inhibition (HI) assay. Hence the crude protein was checked 
for its haemagglutination activity with 1% washed chicken 
RBC using “U” bottom 96 well micro haemagglutination 
plates and was found to exhibit haemagglutination titre of 1 
in 40.
  The present study highlighted the possibilities of using 
the expressed protein as diagnostic reagent for HI-assays 
being done routinely in avian diagnostic laboratories mainly 
for monitoring the vaccination efficiency[14],  in commercial 
layers, the HA efficacy of the expressed protein was given 
importance, rather than its immunologic activities.
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